JP2022551198A5 - - Google Patents
Info
- Publication number
- JP2022551198A5 JP2022551198A5 JP2022546590A JP2022546590A JP2022551198A5 JP 2022551198 A5 JP2022551198 A5 JP 2022551198A5 JP 2022546590 A JP2022546590 A JP 2022546590A JP 2022546590 A JP2022546590 A JP 2022546590A JP 2022551198 A5 JP2022551198 A5 JP 2022551198A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- pharmaceutically acceptable
- occurrence
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962911652P | 2019-10-07 | 2019-10-07 | |
| US62/911,652 | 2019-10-07 | ||
| PCT/US2020/054360 WO2021071812A1 (en) | 2019-10-07 | 2020-10-06 | Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551198A JP2022551198A (ja) | 2022-12-07 |
| JP2022551198A5 true JP2022551198A5 (https=) | 2024-05-15 |
| JP7822940B2 JP7822940B2 (ja) | 2026-03-03 |
Family
ID=75436856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546590A Active JP7822940B2 (ja) | 2019-10-07 | 2020-10-06 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリールメチレン複素環式化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220411367A1 (https=) |
| EP (1) | EP4041228A4 (https=) |
| JP (1) | JP7822940B2 (https=) |
| KR (1) | KR20220079881A (https=) |
| CN (1) | CN114727993B (https=) |
| AU (1) | AU2020363360A1 (https=) |
| BR (1) | BR112022006226A2 (https=) |
| CA (1) | CA3157031A1 (https=) |
| IL (1) | IL291869A (https=) |
| MX (1) | MX2022004145A (https=) |
| WO (1) | WO2021071812A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023003841A (es) | 2020-10-06 | 2023-06-23 | De Shaw Res Llc | Compuestos lactámicos como bloqueadores del canal agitador de potasio kv1.3. |
| TW202521512A (zh) | 2023-07-31 | 2025-06-01 | 美商美國禮來大藥廠 | Kv1.3鉀shaker通道阻斷劑之固體形式及其使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1289471C (zh) * | 2001-04-16 | 2006-12-13 | 先灵公司 | 作为cxc－趋化因子受体配体的3,4－二取代的环丁烯－1,2－二酮 |
| EP2136806A4 (en) * | 2007-03-21 | 2011-11-23 | Creative Antibiotics Sweden Ab | METHOD AND MEANS FOR PREVENTING AND SUPPRESSING TYPE III SECRETION IN INFECTIONS BY GRAM-NEGATIVE BACTERIA |
| TW201026708A (en) * | 2008-12-12 | 2010-07-16 | Solvay Pharm Bv | Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers |
| WO2013056153A1 (en) * | 2011-10-13 | 2013-04-18 | Kung Charles | Activators of pyruvate kinase m2 and methods of treating disease |
| CA2969295A1 (en) * | 2016-06-06 | 2017-12-06 | Pfizer Inc. | Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor |
| EP3548480A1 (en) * | 2016-11-29 | 2019-10-09 | Epizyme, Inc. | Compounds containing a sulfonic group as kat inhibitors |
| EP3672582B1 (en) * | 2017-08-22 | 2026-04-15 | Cedars-Sinai Medical Center | Compositions and methods for treating cancer |
-
2020
- 2020-10-06 CN CN202080084714.9A patent/CN114727993B/zh active Active
- 2020-10-06 KR KR1020227013512A patent/KR20220079881A/ko not_active Withdrawn
- 2020-10-06 CA CA3157031A patent/CA3157031A1/en active Pending
- 2020-10-06 WO PCT/US2020/054360 patent/WO2021071812A1/en not_active Ceased
- 2020-10-06 AU AU2020363360A patent/AU2020363360A1/en not_active Abandoned
- 2020-10-06 JP JP2022546590A patent/JP7822940B2/ja active Active
- 2020-10-06 IL IL291869A patent/IL291869A/en unknown
- 2020-10-06 EP EP20874457.3A patent/EP4041228A4/en active Pending
- 2020-10-06 BR BR112022006226A patent/BR112022006226A2/pt not_active IP Right Cessation
- 2020-10-06 US US17/766,889 patent/US20220411367A1/en active Pending
- 2020-10-06 MX MX2022004145A patent/MX2022004145A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022550640A5 (https=) | ||
| JP2022551197A5 (https=) | ||
| JP2022552445A5 (https=) | ||
| JP2022550641A5 (https=) | ||
| JP2023539584A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP4724665B2 (ja) | キノリノン化合物を合成する方法 | |
| JP2022541825A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| JP2013530236A5 (https=) | ||
| JP2022551198A5 (https=) | ||
| WO2018022282A1 (en) | Novel therapeutic agents for the treatment of hbv infection | |
| KR20210049858A (ko) | Jak 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리딘 화합물 및 이의 용도 | |
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| WO2008076356A1 (en) | Novel oxadiazole compounds | |
| JP2015533782A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2021502387A5 (https=) | ||
| JP2022519239A5 (https=) | ||
| JP2025505644A5 (https=) | ||
| JP2010526867A5 (https=) | ||
| JP2023164918A5 (https=) | ||
| JP2020537671A5 (https=) | ||
| JP7851934B2 (ja) | 神経変性疾患の治療のための、インダニルを含むカルボン酸化合物 | |
| CN115066425A (zh) | Jak抑制剂在制备治疗jak激酶相关疾病药物中的应用 | |
| JP2024522718A (ja) | 神経変性疾患の治療のための、カルボン酸基を含むアゼチジニル化合物 |